# Commission Regulation (EU) No 283/2013 of 1 March 2013 setting out the data requirements for active substances, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (Text with EEA relevance), Division 5.8.3: Endocrine disrupting properties

Extent: E+W+S+N.I.

If there is evidence that the active substance may have endocrine disrupting properties, additional information or specific studies shall be required:
to elucidate the mode/mechanism of action,
to provide sufficient evidence for relevant adverse effects.
Studies required shall be designed on an individual basis and taking into account national or internationally agreed guidelines, in the light of the particular parameters to be investigated and the objectives to be achieved.

---
Source: https://www.legislation.gov.uk/eur/2013/283/annex/section/5/division/5.8/division/5.8.3 (the official version)
Page: https://openlegislation.uk/eu-regulation-2013-283/annex/section-5/division-5.8/division-5.8.3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.